| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.068 | 0.8 |